Nakabayashi Keisuke, Sunaga Daisuke, Kaneko Nobuhito, Matsui Akihiro, Tanaka Kazuhiko, Ando Hiroshi, Shimizu Minoru
Kasukabe Chuo General Hospital, Heart Center, Saitama, Japan.
Kasukabe Chuo General Hospital, Heart Center, Saitama, Japan.
Cardiovasc Revasc Med. 2019 Apr;20(4):293-302. doi: 10.1016/j.carrev.2018.10.022. Epub 2018 Oct 26.
Excimer laser coronary atherectomy (ELCA), a unique percutaneous coronary intervention (PCI) device, comprises a monorail-type system and is compatible with any standard 0.014-inch guidewire. ELCA is the only device that vaporizes the atherosclerotic plaques or modifies underlying plaque located underneath to a hard tissue, such as severe calcification or a stent. Therefore, ELCA differs from other coronary atherectomy devices and is useful for patients with acute coronary syndrome, chronic total occlusion or under-expanded stents. This case series reports on patients treated using ELCA to simplify complex PCI procedures. Furthermore, we review and discuss ELCA in several situations.
准分子激光冠状动脉斑块切除术（ELCA）是一种独特的经皮冠状动脉介入治疗（PCI）设备，它由单轨式系统组成，并且与任何标准的0.014英寸导丝兼容。ELCA是唯一一种能够汽化动脉粥样硬化斑块或将其下方的潜在斑块转变为硬组织（如严重钙化或支架）的设备。因此，ELCA不同于其他冠状动脉斑块切除设备，对急性冠状动脉综合征、慢性完全闭塞或支架扩张不足的患者有用。本病例系列报告了使用ELCA治疗以简化复杂PCI手术的患者。此外，我们在几种情况下回顾并讨论了ELCA。
